Details
Stereochemistry | ACHIRAL |
Molecular Formula | C8H14N2O.ClH |
Molecular Weight | 190.671 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CO\N=C\C1=CCCN(C)C1
InChI
InChIKey=WEBMRZODPLSRKR-MLBSPLJJSA-N
InChI=1S/C8H14N2O.ClH/c1-10-5-3-4-8(7-10)6-9-11-2;/h4,6H,3,5,7H2,1-2H3;1H/b9-6+;
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C8H14N2O |
Molecular Weight | 154.2096 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Optical Activity | NONE |
Milameline (previously known as RU 35926/CI-979), a partial muscarinic agonist that was developed as a cognition-enhancing agent for the treatment of patients with Alzheimer's disease. In spite of this drug has achieved phase III clinical trials, further studies were apparently discontinued.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10188788
CI-979/RU35926 (milameline) was well tolerated at doses of 0.002-1.0 mg with cholinergic symptoms such as hypersalivation and sweating, observed at 2-4 mg.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:26:30 GMT 2025
by
admin
on
Mon Mar 31 21:26:30 GMT 2025
|
Record UNII |
W867E71LPD
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C47796
Created by
admin on Mon Mar 31 21:26:30 GMT 2025 , Edited by admin on Mon Mar 31 21:26:30 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
9571001
Created by
admin on Mon Mar 31 21:26:30 GMT 2025 , Edited by admin on Mon Mar 31 21:26:30 GMT 2025
|
PRIMARY | |||
|
DTXSID901350263
Created by
admin on Mon Mar 31 21:26:30 GMT 2025 , Edited by admin on Mon Mar 31 21:26:30 GMT 2025
|
PRIMARY | |||
|
C91040
Created by
admin on Mon Mar 31 21:26:30 GMT 2025 , Edited by admin on Mon Mar 31 21:26:30 GMT 2025
|
PRIMARY | |||
|
300000055292
Created by
admin on Mon Mar 31 21:26:30 GMT 2025 , Edited by admin on Mon Mar 31 21:26:30 GMT 2025
|
PRIMARY | |||
|
GG-92
Created by
admin on Mon Mar 31 21:26:30 GMT 2025 , Edited by admin on Mon Mar 31 21:26:30 GMT 2025
|
PRIMARY | |||
|
139886-04-7
Created by
admin on Mon Mar 31 21:26:30 GMT 2025 , Edited by admin on Mon Mar 31 21:26:30 GMT 2025
|
PRIMARY | |||
|
W867E71LPD
Created by
admin on Mon Mar 31 21:26:30 GMT 2025 , Edited by admin on Mon Mar 31 21:26:30 GMT 2025
|
PRIMARY | |||
|
CHEMBL151938
Created by
admin on Mon Mar 31 21:26:30 GMT 2025 , Edited by admin on Mon Mar 31 21:26:30 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |